Yufeng Shang

671 citations
30 papers · 443 indexed · h-index 10
Topics
COVID-19 Clinical Research Studies (6 papers)Multiple Myeloma Research and Treatments (5 papers)SARS-CoV-2 and COVID-19 Research (4 papers)
Journals
SHILAP Revista de lepidopterologíaBloodOncogene
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Yufeng Shang

28 papers receiving 437 citations

Peers

Yufeng Shang
Comparison fields: 5 of 86
  • Molecular Biology 131
  • Infectious Diseases 130
  • Oncology 108
  • Neurology 94
  • Cancer Research 53
Replace Kyung D. Moon with:
Kyung D. Moon United States
Arianna Damiani Italy
Jamil Azzi United States
Lai Xu Canada
Deepak Atri United States
Maria Giuseppina Cefalo Italy
Yibin Zhang China
Chelsea Kotch United States
Frank Aboubakar Nana Belgium
Yufeng Shang relative to Kyung D. Moon United States Kyung D. Moon's profile →
Citations per field
00.5×5.8×
Kyung D. Moon · 1×
Citations per year

Countries citing papers authored by Yufeng Shang

Since Specialization
Citations

This map shows the geographic impact of Yufeng Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Shang more than expected).

Fields of papers citing papers by Yufeng Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Shang. The network helps show where Yufeng Shang may publish in the future.

Co-authorship network of co-authors of Yufeng Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Shang. A scholar is included among the top collaborators of Yufeng Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Shang. Yufeng Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 6
3 1
4 0
5 4
6 1
7 7
8 1
9 4
10 51
11 2
12 1
13 43
14 1
15 116
16 17
17 3
18 20
19 4
20 13

About Yufeng Shang

Yufeng Shang is a scholar working on Complementary and Manual Therapy, Hematology and Genetics, having authored 30 papers that have together received 443 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Multiple Myeloma Research and Treatments (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Infectious Diseases (130 citations), Neurology (94 citations) and Genetics (52 citations). Yufeng Shang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Fuling Zhou, Yongchang Wei, Tao Liu, Liang Shao, Xinghuan Wang, Zhigang Zhao, Minghui Liu, Yongxi Zhang, Zhiyong Peng and Jingfeng Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026